studies on the role of HDAC inhibitors to reverse cisplatin resistance in animal models with ovarian cancer developed using tumor tissue from patients
Not Applicable
- Conditions
- Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
- Registration Number
- CTRI/2021/04/033090
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who are diagnosed with ovarian cancer posted for debulking surgery
Patients who are diagnosed with ovarian cancer posted for ascetic fluid aspiration
Patients with age group > 18 years
Exclusion Criteria
Patients who have received chemotherapy before surgery
Patients who have received chemotherapy before ascetic fluid aspiration
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method